Jump to main content
Jump to site search
Access to RSC content Close the message box

Continue to access RSC content when you are not at your institution. Follow our step-by-step guide.


Issue 21, 2018
Previous Article Next Article

A liver-immune coculture array for predicting systemic drug-induced skin sensitization

Author affiliations

Abstract

Drug-induced skin sensitization is prevalent worldwide and can trigger life-threatening health conditions, such as Stevens Johnson Syndrome. However, existing in vitro skin models cannot adequately predict the skin sensitization effects of drugs administered into the systemic circulation because dermal inflammation and injury are preceded by conversion of parent drugs into antigenic reactive metabolites in the liver and subsequent activation of the immune system. Here, we demonstrate that recapitulation of these early tandem cellular processes in a compartmentalized liver-immune coculture array is sufficient to predict the skin sensitization potential of systemic drugs. Human progenitor cell (HepaRG)-derived hepatocyte spheroids and U937 myeloid cells, a representative antigen presenting cell (APC), can maintain their respective functions in 2 concentric micro-chambers, which are connected by a diffusion microchannel network. Paradigm drugs that are reported to cause severe cutaneous drug reactions (i.e. carbamazepine, phenytoin and allopurinol) can be metabolized into their reactive metabolites, which diffuse efficiently into the adjoining immune compartment within a 48 hour period. By measuring the extent of U937 activation as indicated by IL8, IL1β and CD86 upregulation upon drug administration, we show that the liver-immune coculture array more consistently and reliably distinguish all 3-paradigm skin sensitizing drugs from a non-skin sensitizer than conventional bulk Transwell coculture. Given its miniaturized format, design simplicity and prediction capability, this novel in vitro system can be readily scaled into a screenable platform to identify the skin sensitization potential of systemically-administered drugs.

Graphical abstract: A liver-immune coculture array for predicting systemic drug-induced skin sensitization

Back to tab navigation

Supplementary files

Article information


Submitted
01 Aug 2018
Accepted
21 Sep 2018
First published
21 Sep 2018

Lab Chip, 2018,18, 3239-3250
Article type
Paper

A liver-immune coculture array for predicting systemic drug-induced skin sensitization

L. H. Chong, H. Li, I. Wetzel, H. Cho and Y. Toh, Lab Chip, 2018, 18, 3239
DOI: 10.1039/C8LC00790J

Social activity

Search articles by author

Spotlight

Advertisements